Comprehensive review reveals diagnostic accuracy of exhaled breath analysis using VOCs, indicating pivotal advancements in disease detection.
Exhaled breath analysis (EBA) is an advanced, non-invasive diagnostic technique that utilizes volatile organic compounds (VOCs) to detect and monitor various diseases. This review examines EBA’s historical development and current status as a promising diagnostic tool. It highlights the significant contributions of modern methods such as gas chromatography–mass spectrometry (GC-MS), ion mobility spectrometry (IMS), and electronic noses in enhancing the sensitivity and specificity of EBA. Furthermore, it emphasizes the transformative role of nanotechnology and machine learning in improving the diagnostic accuracy of EBA. Despite challenges such as standardization and environmental factors, which must be addressed for the widespread adoption of this technique, EBA shows excellent potential for early disease detection and personalized medicine. The review also highlights the potential of photonic crystal fiber (PCF) sensors, known for their superior sensitivity, in the field of EBA.
No takes yet. Share an insight, caveat, or question.
Mortazavi et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: